- Home
- IRMD vs TERN Comparison
IRMD vs TERN Comparison
Compare IRMD & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- TERN
- Stock Information
- Founded
- IRMD 1992
- TERN 2017
- Country
- IRMD United States
- TERN United States
- Employees
- IRMD N/A
- TERN N/A
- Industry
- IRMD Medical/Dental Instruments
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- IRMD Health Care
- TERN Health Care
- Exchange
- IRMD Nasdaq
- TERN Nasdaq
- Market Cap
- IRMD 618.5M
- TERN 499.4M
- IPO Year
- IRMD 2014
- TERN 2021
- Fundamental
- Price
- IRMD $54.20
- TERN $6.25
- Analyst Decision
- IRMD Strong Buy
- TERN Buy
- Analyst Count
- IRMD 1
- TERN 5
- Target Price
- IRMD $60.00
- TERN $18.30
- AVG Volume (30 Days)
- IRMD 43.3K
- TERN 1.8M
- Earning Date
- IRMD 02-06-2025
- TERN 11-12-2024
- Dividend Yield
- IRMD 1.12%
- TERN N/A
- EPS Growth
- IRMD 13.16
- TERN N/A
- EPS
- IRMD 1.46
- TERN N/A
- Revenue
- IRMD $71,305,130.00
- TERN N/A
- Revenue This Year
- IRMD $13.29
- TERN N/A
- Revenue Next Year
- IRMD $10.76
- TERN N/A
- P/E Ratio
- IRMD $36.62
- TERN N/A
- Revenue Growth
- IRMD 13.23
- TERN N/A
- 52 Week Low
- IRMD $40.18
- TERN $4.32
- 52 Week High
- IRMD $57.95
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- IRMD 46.78
- TERN 48.82
- Support Level
- IRMD $51.75
- TERN $6.41
- Resistance Level
- IRMD $56.50
- TERN $7.14
- Average True Range (ATR)
- IRMD 1.41
- TERN 0.45
- MACD
- IRMD -0.26
- TERN 0.07
- Stochastic Oscillator
- IRMD 24.11
- TERN 40.27
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.